Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Targeted Oncologics Will Sustain High Prices With Clear Benefits, GSK Says

Dec 05 2005

• By The Pink Sheet

Related Content

Cancer Drugs Will Continue To Command High Prices, Scully Predicts

Nov 15 2004

Genentech Avastin Clears FDA; Colorectal Cancer Drug Costs $4,400 A Month

Mar 01 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window